search
Back to results

Diet for Colonoscopy Preparation in Diabetic Patients (DIMEPREP)

Primary Purpose

Diabetes Mellitus, Colonic Diseases

Status
Completed
Phase
Phase 3
Locations
Spain
Study Type
Interventional
Intervention
Low-residue diet
Usual care
Sponsored by
Parc de Salut Mar
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Diabetes Mellitus focused on measuring Colonoscopy, Diabetes Mellitus, Diet, Polyethylene glycols, Efficacy, Personal satisfaction

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients scheduled for a diagnostic, screening or follow-up outpatient colonoscopy
  • Diabetes mellitus (being treated with insulin or any oral agent).

Exclusion Criteria:

  • Unwillingness to participate.
  • Hospital admission at the time of colonoscopy.
  • Inability to follow instructions
  • Active inflammatory bowel disease
  • Previous colectomy.
  • Incomplete colonoscopies due to technical reasons or contraindication for the procedure as evaluated by the endoscopist

Sites / Locations

  • Hospital Germans Trias i Pujol
  • Hospital del Mar

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Low-residue diet

Usual care

Arm Description

Subjects will follow a low-residue diet for 4 days. Their usual treatment for diabetes will be adjusted to the degree of glycemic control.

Subjects will follow a low-residue diet for 3 days (from 4 to 2 days before the procedure) and a liquid diet on the following day (the one before the procedure). No changes in their treatment for diabetes will be made

Outcomes

Primary Outcome Measures

Efficacy of the bowel preparation
Rating of the Boston Bowel Preparation Scale (BBPS) by the endoscopist

Secondary Outcome Measures

Cecal intubation
Ratio of successful cecal intubations in each study arm
Polyp and adenoma detection
Ratio of polyps and adenomas detected in each study arm
Symptomatic hypoglycemia
Each participant will report his/her experience in a questionnaire
Abdominal pain, nausea, hunger and bloating
Each participant will rate his/her experience in an analogue visual scale
Adverse events
Description of all spontaneously reported adverse events.
Adherence to the planned bowel cleansing method (questionnaire)
Each participant will rate his/her experience in a questionnaire.
Acceptability of the preparation (interference with work, leisure activities or sleep
Each participant will rate his/her experience in a questionnaire.
Predictors of inadequate bowel preparation
Independent predictors will be identified by multivariate analysis

Full Information

First Posted
November 21, 2014
Last Updated
April 11, 2016
Sponsor
Parc de Salut Mar
Collaborators
Germans Trias i Pujol Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02300779
Brief Title
Diet for Colonoscopy Preparation in Diabetic Patients
Acronym
DIMEPREP
Official Title
Randomized Clinical Trial on the Efficacy of an Adapted Bowel Preparation for Diabetic Patients Undergoing a Colonoscopy. DIMEPREP Study
Study Type
Interventional

2. Study Status

Record Verification Date
April 2016
Overall Recruitment Status
Completed
Study Start Date
December 2014 (undefined)
Primary Completion Date
July 2015 (Actual)
Study Completion Date
October 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Parc de Salut Mar
Collaborators
Germans Trias i Pujol Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This trial will compare the efficacy of to 2 different sets of dietary recommendations to be followed before colon cleansing for colonoscopy in diabetic patients.
Detailed Description
Consecutive diabetic patients undergoing an ambulatory colonoscopy at the participating sites will be randomized to follow one of two different sets of dietary recommendations. The experimental group will be asked to start a low-residue diet 4 days before the procedure, during which the therapy for diabetes will be adjusted. The control group will be asked to follow a low-residue diet for 3 days followed by a liquid diet during the day before the procedure, and no adjustments will be made to their usual treatment. Colon cleansing will be undertaken with polyethylene glycol (4 liters in the usual split administration scheme) in both groups. Analogic visual scales and standardized questionnaires on various aspects that may influence the degree of satisfaction about the preparation will be answered by the participants and collected before the colonoscopy. The endoscopist, blinded to the preparation method, will grade the adequacy of the preparation. Adverse events will be recorded up to 1 month after the procedure

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Colonic Diseases
Keywords
Colonoscopy, Diabetes Mellitus, Diet, Polyethylene glycols, Efficacy, Personal satisfaction

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Care Provider
Allocation
Randomized
Enrollment
150 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Low-residue diet
Arm Type
Experimental
Arm Description
Subjects will follow a low-residue diet for 4 days. Their usual treatment for diabetes will be adjusted to the degree of glycemic control.
Arm Title
Usual care
Arm Type
Active Comparator
Arm Description
Subjects will follow a low-residue diet for 3 days (from 4 to 2 days before the procedure) and a liquid diet on the following day (the one before the procedure). No changes in their treatment for diabetes will be made
Intervention Type
Dietary Supplement
Intervention Name(s)
Low-residue diet
Intervention Description
Subjects will be instructed by members of the research team to follow a low-residue diet for 4 days. Bowel cleansing will begin at 9:00 pm on the evening before the colonoscopy is scheduled. Participants will take 8 sachets of the investigational product and take their contents diluted in 2 liters of water. Eight other sachets, also diluted in 2 liters of water will be taken 4 to 5 hours before the procedure. Fasting will be required from 2 hours after the bowel cleansing is complete. Their usual treatment for diabetes (whether insulin or an oral agent) will be adjusted.
Intervention Type
Dietary Supplement
Intervention Name(s)
Usual care
Intervention Description
Subjects will be instructed by members of the research team to follow a low-residue diet for 3 days followed by a liquid-only diet for an additional day. Bowel cleansing will begin at 9:00 pm on the evening before the colonoscopy is scheduled. Participants will take 8 sachets of the investigational product and take their contents diluted in 2 liters of water. Eight other sachets, also diluted in 2 liters of water will be taken 4 to 5 hours before the procedure. Fasting will be required from 2 hours after the bowel cleansing is complete. No modifications in their usual treatment will be made.
Primary Outcome Measure Information:
Title
Efficacy of the bowel preparation
Description
Rating of the Boston Bowel Preparation Scale (BBPS) by the endoscopist
Time Frame
1 hour after the colonoscopy
Secondary Outcome Measure Information:
Title
Cecal intubation
Description
Ratio of successful cecal intubations in each study arm
Time Frame
1 hour after the colonoscopy
Title
Polyp and adenoma detection
Description
Ratio of polyps and adenomas detected in each study arm
Time Frame
1 hour after the colonoscopy
Title
Symptomatic hypoglycemia
Description
Each participant will report his/her experience in a questionnaire
Time Frame
6 hours after finishing bowel preparation
Title
Abdominal pain, nausea, hunger and bloating
Description
Each participant will rate his/her experience in an analogue visual scale
Time Frame
6 hours after finishing bowel preparation
Title
Adverse events
Description
Description of all spontaneously reported adverse events.
Time Frame
30 days after the colonoscopy
Title
Adherence to the planned bowel cleansing method (questionnaire)
Description
Each participant will rate his/her experience in a questionnaire.
Time Frame
6 hours after finishing bowel preparation
Title
Acceptability of the preparation (interference with work, leisure activities or sleep
Description
Each participant will rate his/her experience in a questionnaire.
Time Frame
6 hours after finishing bowel preparation
Title
Predictors of inadequate bowel preparation
Description
Independent predictors will be identified by multivariate analysis
Time Frame
Baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients scheduled for a diagnostic, screening or follow-up outpatient colonoscopy Diabetes mellitus (being treated with insulin or any oral agent). Exclusion Criteria: Unwillingness to participate. Hospital admission at the time of colonoscopy. Inability to follow instructions Active inflammatory bowel disease Previous colectomy. Incomplete colonoscopies due to technical reasons or contraindication for the procedure as evaluated by the endoscopist
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marco Antonio Alvarez González, MD, PhD
Organizational Affiliation
Parc de Salut Mar
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Germans Trias i Pujol
City
Badalona
State/Province
Barcelona
ZIP/Postal Code
08916
Country
Spain
Facility Name
Hospital del Mar
City
Barcelona
ZIP/Postal Code
08003
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
11280539
Citation
Taylor C, Schubert ML. Decreased efficacy of polyethylene glycol lavage solution (golytely) in the preparation of diabetic patients for outpatient colonoscopy: a prospective and blinded study. Am J Gastroenterol. 2001 Mar;96(3):710-4. doi: 10.1111/j.1572-0241.2001.03610.x.
Results Reference
background
PubMed Identifier
19582466
Citation
Ozturk NA, Gokturk HS, Demir M, Erdogan D, Unler GK, Gur G, Yilmaz U. The effect of autonomous neuropathy on bowel preparation in type 2 diabetes mellitus. Int J Colorectal Dis. 2009 Dec;24(12):1407-12. doi: 10.1007/s00384-009-0757-4. Epub 2009 Jul 7.
Results Reference
background
PubMed Identifier
18978506
Citation
Chung YW, Han DS, Park KH, Kim KO, Park CH, Hahn T, Yoo KS, Park SH, Kim JH, Park CK. Patient factors predictive of inadequate bowel preparation using polyethylene glycol: a prospective study in Korea. J Clin Gastroenterol. 2009 May-Jun;43(5):448-52. doi: 10.1097/MCG.0b013e3181662442.
Results Reference
background
PubMed Identifier
27490086
Citation
Alvarez-Gonzalez MA, Flores-Le Roux JA, Seoane A, Pedro-Botet J, Carot L, Fernandez-Clotet A, Raga A, Pantaleon MA, Barranco L, Bory F, Lorenzo-Zuniga V. Efficacy of a multifactorial strategy for bowel preparation in diabetic patients undergoing colonoscopy: a randomized trial. Endoscopy. 2016 Nov;48(11):1003-1009. doi: 10.1055/s-0042-111320. Epub 2016 Aug 4.
Results Reference
derived

Learn more about this trial

Diet for Colonoscopy Preparation in Diabetic Patients

We'll reach out to this number within 24 hrs